Abiopharma

🔍 BENDHEIM JACK (Director)

Company: PHIBRO ANIMAL HEALTH CORP (PAHC)

Report Date: 2026-08-06

Detailed Transactions and Holdings:

• Acquired 12,103 shares of Class A Common Stock (Direct)
  Date: 2026-08-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 26,640.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-06 | Code: H | nature_of_ownership: See | shares_owned_after: 56,152.00 | Footnotes: F4

Footnotes:

• F1: The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.
• F2: The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.
• F3: The reported securities are directly held by Jack Bendheim.
• F4: The reported securities are directly held by BFI Co., LLC ("BFI"). Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.